Related Experiment Video
Updated: Aug 17, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Cancer genes: rare recombinants instead of activated oncogenes (a review)
Abstract:
The 20 known transforming (onc) genes of retroviruses are defined by sequences that are transduced from cellular genes termed protooncogenes or cellular oncogenes. Based on these sequences, viral onc genes have been postulated to be transduced cellular cancer genes, and proto-onc genes have been postulated to be latent cancer genes that can be activated from within the cell to cause virus-negative tumors. The hypothesis is popular because it promises direct access to cellular cancer genes. However, the existence of latent cancer genes presents a paradox, since such genes are clearly undesirable. The hypothesis predicts that viral onc genes and proto-onc genes are isogenic; that expression of proto-onc genes induces tumors; that activated proto-onc genes transform diploid cells upon transfection, like viral onc genes; and that diploid tumors exist. As yet, none of these predictions is confirmed. Instead: Structural comparisons between viral onc genes, essential retroviral genes, and proto-onc genes show that all viral onc genes are indeed new genes, rather than transduced cellular cancer genes. They are recombinants put together from truncated viral and truncated proto-onc genes. Proto-onc genes are frequently expressed in normal cells. To date, not one activated proto-onc gene has been isolated that transforms diploid cells. Above all, no diploid tumors with activated proto-onc genes have been found. Moreover, the probability of spontaneous transformation in vivo is at least 10(9) times lower than predicted from the mechanisms thought to activate proto-onc genes. Therefore, the hypothesis that proto-onc genes are latent cellular oncogenes appears to be an overinterpretation of sequence homology to structural and functional homology with viral onc genes. Here it is proposed that only rare truncations and illegitimate recombinations that alter the germ-line configuration of cellular genes generate viral and possibly cellular cancer genes. The clonal chromosome abnormalities that are consistently found in tumor cells are microscopic evidence for rearrangements that may generate cancer genes. The clonality indicates that the tumors are initiated with, and possibly by, these abnormalities, as predicted by Boveri in 1914.
Insights
Viral oncogenes are new recombinants, not transduced cellular cancer genes. Proto-oncogenes are not latent cancer genes; rare genetic alterations likely generate cancer genes, supported by tumor cell chromosomal abnormalities.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Retroviral oncogenes (onc) are derived from cellular proto-oncogenes.
- A popular hypothesis suggests proto-oncogenes are latent cancer genes activated in virus-negative tumors.
- This hypothesis implies direct access to cellular cancer genes.
Purpose of the Study:
- To investigate the origin and function of viral oncogenes and proto-oncogenes.
- To evaluate the hypothesis that proto-oncogenes act as latent cellular oncogenes.
- To propose an alternative mechanism for cancer gene generation.
Main Methods:
- Structural comparison of viral oncogenes, retroviral genes, and proto-oncogenes.
- Analysis of proto-oncogene expression in normal cells.
- Examination of experimental data on cell transformation and tumor formation.
Main Results:
- Viral oncogenes are novel recombinants of truncated viral and proto-oncogenes, not direct transductions.
- Proto-oncogenes are commonly expressed in normal cells.
- No evidence supports proto-oncogenes as latent cancer genes inducing tumors; experimental predictions remain unconfirmed.
Conclusions:
- The hypothesis of proto-oncogenes as latent cellular oncogenes is an overinterpretation.
- Cancer genes likely arise from rare germ-line alterations, truncations, and illegitimate recombinations.
- Clonal chromosomal abnormalities in tumors provide evidence for rearrangements generating cancer genes.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

